All Type of News


440 companies founded last year, giving prediction of 2nd bio-venture boom

The 2nd bio-venture boom was predicted as more than 440 bio small and medium companies were founded last year.  According to data of the ‘Korean biotechnology small and medium venture foundation status’ recently publ...

What are 8 pharmaceutical policies suggested to Planning Advisory Committee for National Affairs?

While the Jae-In Moon administration shared empathy about ‘medical publicity’ with 5 medical associations, the Korean Pharmaceutical Association(hereinafter referring to KPA) suggested 8 pending policy issues includin...

“Saudi Arabia is considering a 30-approval process for Korean drugs”

“We are considering a 30-day approval process for pharmaceutical products that are already approved from the Korean Ministry of Food and Drug Safety.” Mr. Al-Hariri, a person in charge for pharmaceutical affairs in S...

MFDS revises indicated information on OTC drugs to be easily understood

On the 20th of June, the Ministry of Food and Drug Safety pre-announced a partial revision bill to the ‘Regulations for Pharmaceutical Drug Labeling’ having creation of the entire substance indication method with indi...

Hanmi’s 3-sbustance combination drug containing Amosartan & rosuvastatin represented at EHS

2 case results of clinical trial for ‘Amosartan,’ a combination drug developed by Hanmi Pharm, were announced at the European Society of Hypertension(ESH). Hanmi Pharm announced on the 20th that it presented a Phase ...

Government conducts study about detailed plans for ‘introduction of public pharmaceutical control tower’

The government will start a study of detailed plan for the ‘Introduction of Pharmaceutical Control Tower’ to supply essential drugs. In the process, it will review various aspects, such as definition of essential drug...

MFDS strengthens post-marketing drug safety management

The Ministry of Food and Drug Safety(MFDS) will strengthen post-marketing drug safety control to minimize consumer damages from drug side effects. In order to overcome unexpected side effects after pharmaceutical app...

‘Aggregation Labeling Standards’ approaching

The ‘Aggregation Labeling Standards,’ a key factor of implementing the serial number reporting system next month, is going to be completed soon. The government – Ministry of Health and Welfare(MOHW) & Health Insuranc...

MFDS provides information about approval expiration date in preparation of product renewal system

In order to give a guidance about details of the ‘Pharmaceutical Product Renewal System’ which will be enforced from coming July, the Ministry of Food and Drug Safety(MFDS) will open the ‘Information Room about Pharma...

SK Biotek acquires Bristol-Myers Squibb’s factory in Ireland

SK Group will acquire a factory of Bristol-Myers Squibb(BMS), a global pharmaceutical company, in Ireland. “Our subsidiary, SK Biotek, will acquire a Bristol-Myers Squibb’s large pharmaceutical ingredient factory(pro...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.